hydroxamic acid mmpi Search Results


4-abz-gly-pro-d-leu-d-ala-nhoh trifluoroacetate salt  (Chem Impex International)
N/A
   Buy from Supplier
hydroxamic acid mmp inhibitor inh 3850 pi  (Biosynth Carbosynth)
92
Biosynth Carbosynth hydroxamic acid mmp inhibitor inh 3850 pi
Hydroxamic Acid Mmp Inhibitor Inh 3850 Pi, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/10__1074_slash_jbc__m005631200-49-2-11?v=Biosynth+Carbosynth
Average 92 stars, based on 1 article reviews
hydroxamic acid mmp inhibitor inh 3850 pi - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
bb-16  (DuPont de Nemours)
90
DuPont de Nemours bb-16
Bb 16, supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pm10037754-53-1-18?v=DuPont+de+Nemours
Average 90 stars, based on 1 article reviews
bb-16 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
3-( n -hydroxycarbamoyl)-2(r)-isobutylpropionyl- l -tryptophan methylamide (gm6001)  (Glycomed Research Inc)
90
Glycomed Research Inc 3-( n -hydroxycarbamoyl)-2(r)-isobutylpropionyl- l -tryptophan methylamide (gm6001)
3 ( N Hydroxycarbamoyl) 2(r) Isobutylpropionyl L Tryptophan Methylamide (Gm6001), supplied by Glycomed Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pmc02132651-20-33-64?v=Glycomed+Research+Inc
Average 90 stars, based on 1 article reviews
3-( n -hydroxycarbamoyl)-2(r)-isobutylpropionyl- l -tryptophan methylamide (gm6001) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hydroxamic acid derivatives  (Enzo Biochem)
90
Enzo Biochem hydroxamic acid derivatives
Design of multitarget α v β 3 <t>-MMP2</t> tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.
Hydroxamic Acid Derivatives, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pmc08879803-291-4-23?v=Enzo+Biochem
Average 90 stars, based on 1 article reviews
hydroxamic acid derivatives - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
mmp3 inhibitor nngh  (Biomol GmbH)
90
Biomol GmbH mmp3 inhibitor nngh
Design of multitarget α v β 3 <t>-MMP2</t> tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.
Mmp3 Inhibitor Nngh, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pmc03501968-128-6-21?v=Biomol+GmbH
Average 90 stars, based on 1 article reviews
mmp3 inhibitor nngh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
fn-439 metalloproteinase inhibitor  (Merck KGaA)
90
Merck KGaA fn-439 metalloproteinase inhibitor
Design of multitarget α v β 3 <t>-MMP2</t> tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.
Fn 439 Metalloproteinase Inhibitor, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pm26945033-37-8-17?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
fn-439 metalloproteinase inhibitor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hydroxamic acid  (Verlag GmbH)
90
Verlag GmbH hydroxamic acid
Design of multitarget α v β 3 <t>-MMP2</t> tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.
Hydroxamic Acid, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pm23280962-104-21-7?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
hydroxamic acid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
mmp inhibitor i  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology mmp inhibitor i
Design of multitarget α v β 3 <t>-MMP2</t> tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.
Mmp Inhibitor I, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pm28098359-109-44-50?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
mmp inhibitor i - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
the mmp-9 inhibitor  (Merck KGaA)
90
Merck KGaA the mmp-9 inhibitor
Design of multitarget α v β 3 <t>-MMP2</t> tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.
The Mmp 9 Inhibitor, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hydroxamic+acid+mmpi/pm17939964-121-18-48?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
the mmp-9 inhibitor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
4-aminobenzoyl-gly-pro-d-leu-d-ala hydroxamic acid  (Santa Cruz Biotechnology)
N/A
4-Aminobenzoyl-Gly-Pro-D-Leu-D-Ala hydroxamic acid, also called MMP Inhibitor I, is a broad spectrum inhibitor of MMP-1 and MMP-8 (collgenases, IC50=1.0μM), MMP-9 (granulocyte gelatinase, IC50=50μM), and MMP-3 (skin fibroblast stromelysin, IC50=50μM).
   Buy from Supplier
nngh  (Cayman Chemical)
N/A
NNGH is a cell permeable broad spectrum inhibitor of matrix metalloproteinases MMPs It blocks the activity of MMP 8 9 12 13 and 20 with K values of 9 2 6 4 3 3 1
   Buy from Supplier

Image Search Results


Design of multitarget α v β 3 -MMP2 tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.

Journal: Molecules

Article Title: Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis

doi: 10.3390/molecules27041249

Figure Lengend Snippet: Design of multitarget α v β 3 -MMP2 tyrosine-derived peptidomimetics; ( left ) binding mode of Kessler’s peptidomimetic within α v β 3 ; ( right ) hypothesized binding mode of designed sulfonamido tyrosine peptidomimetics within MMP2 catalytic site; R 1 = H, C(NH)NH 2 , R 2 = H, Ph, NO 2 , X = OH, NHOH.

Article Snippet: The inhibition potency of hydroxamic acid derivatives against MMP2 and MMP9 was assayed through a fluorometric assay using the fluorogenic substrate Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 (Enzo life science).

Techniques: Derivative Assay, Binding Assay

Binding activity data of peptidomimetics determined using a fluorogenic peptide substrate a .

Journal: Molecules

Article Title: Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis

doi: 10.3390/molecules27041249

Figure Lengend Snippet: Binding activity data of peptidomimetics determined using a fluorogenic peptide substrate a .

Article Snippet: The inhibition potency of hydroxamic acid derivatives against MMP2 and MMP9 was assayed through a fluorometric assay using the fluorogenic substrate Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 (Enzo life science).

Techniques: Binding Assay, Activity Assay, Inhibition

Dose-response assay curves for compound 19 vs. MMP2 (( a ), IC 50 = 55 nM) and α v β 3 (( b ) IC 50 = 370 nM). IC 50 values were calculated as the concentration of compound required for 50% inhibition of biotinylated vitronectin binding, as estimated by the GraphPad Prism software.

Journal: Molecules

Article Title: Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis

doi: 10.3390/molecules27041249

Figure Lengend Snippet: Dose-response assay curves for compound 19 vs. MMP2 (( a ), IC 50 = 55 nM) and α v β 3 (( b ) IC 50 = 370 nM). IC 50 values were calculated as the concentration of compound required for 50% inhibition of biotinylated vitronectin binding, as estimated by the GraphPad Prism software.

Article Snippet: The inhibition potency of hydroxamic acid derivatives against MMP2 and MMP9 was assayed through a fluorometric assay using the fluorogenic substrate Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 (Enzo life science).

Techniques: Concentration Assay, Inhibition, Binding Assay, Software

Lowest energy conformation resulting from molecular docking of compound 19 within α v β 3 integrin ( a ) and MMP2 (right) binding site. Key residues of the integrin binding site are in magenta ( a ), those of MMP2 in cyan ( b ). Non polar hydrogen atoms are omitted for clarity.

Journal: Molecules

Article Title: Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis

doi: 10.3390/molecules27041249

Figure Lengend Snippet: Lowest energy conformation resulting from molecular docking of compound 19 within α v β 3 integrin ( a ) and MMP2 (right) binding site. Key residues of the integrin binding site are in magenta ( a ), those of MMP2 in cyan ( b ). Non polar hydrogen atoms are omitted for clarity.

Article Snippet: The inhibition potency of hydroxamic acid derivatives against MMP2 and MMP9 was assayed through a fluorometric assay using the fluorogenic substrate Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 (Enzo life science).

Techniques: Binding Assay